Mass spectrometry. Mass spectra were obtained at the UCSD Chemistry and Biochemistry Molecular Mass Spectrometry Facility by using Agilent 6230 Accurate-Mass TOFMS.
Zeta potential. Zeta potential was measured using a Zetasizer (3000 HS, Malvern Instruments Ltd, Worcestershire, UK).
High performance liquid chromatography. HPLC analysis was performed on a Jupiter Proteo90Å phenomenex column (150 × 4.60 mm) using a Hitachi-Elite LaChrom L-2130 pump equipped with a UV-vis detector (Hitachi-Elite LaChrome L-2420). Purification was done using a Jupiter Proteo90 Å Phenomenex column (2050 x 25.0 mm) on a Waters DeltaPrep 300 system. Nanoparticle tracking analysis. Particle concentration of each nano-tracer was obtained by MANTA Instruments (San Diego, CA, USA) using a ViewSizer ® 3000.
Synthesis

Synthesis of 3-(2-((1E,3Z,5E)-5-(1,1-dimethyl-3-(3-sulfopropyl)-1,3-dihydro-2H-benzo[e]indol-2-ylidene)-3-(5-((2-(methacryloyloxy)ethyl)carbamoyl)pyridin-2-yl)penta-1,3-
indol-3-ium-3-yl)propane-1-sulfonate 2 has been reported previously 1 . Carboxyl-Cy 5.5 (Scheme S.1 2) (72 mg, 0.085 mmol), AEMA (28 mg, 0.171 mmol), DMAP (12 mg, 0.0937 mmol) was dissolved in 30 mL of anhydrous DMF under argon. After 10 min, DIPEA (60 µL, 0.342 mmol) was added into the reaction following by adding EDC (15 mg, 0.0936 mmol) with a cold bath surrounding the reaction flask. The reaction was left to stir for 5 hours and cold diethyl ether was added to the reaction and the precipitate was collected and dried under vacuum. The dry dark blue powder was dissolved in buffer A (water with 0.1% TFA) and purified on reverse phase HPLC (gradient 30-60% buffer B, ACN with 0.1%TFA). The pure fractions were collected and lyophilized. 
